Abstract
We performed double high-dose chemotherapy (HDCT) and autologous stem cell rescue (ASCR) on an 8-year-old girl after relapse of Wilms’ tumor with unfavorable histology. Relapse occurred while the patient was still on first-line therapy and showed multiple adverse prognostic features. Since depleted hematopoietic reserves restricted further conventional therapy, a double HDCT approach was chosen to achieve maximal dose intensity. Four years after relapse the girl is in second remission and well. Double HDCT with ASCR may represent a feasible approach to rescue extensively pretreated patients with recurrent Wilms’ tumor of unfavorable histology.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maurer, K., Heitger, A., Schwaighofer, H. et al. Double high-dose chemotherapy with autologous peripheral stem cell rescue in relapsed Wilms’ tumor. Bone Marrow Transplant 20, 1111–1113 (1997). https://doi.org/10.1038/sj.bmt.1701030
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/sj.bmt.1701030